Sesen Bio Inc

Sesen Bio Inc. is a late-stage company developing next-generation antibody-drug conjugate therapies for patients with cancer. The company's product portfolio includes Vicinium(TM) which is in its clinical trial, treats high-grade non-muscle invasive bladder cancer. Sesen Bio Inc., formerly known as Eleven Biotherapeutics, is based in Massachusetts, United States.

Address Details

Address: 245 FIRST STREET SUITE 1800

City: CAMBRIDGE

State: MA

Country: USA

Zip Code: 02142